购物车
- 全部删除
- 您的购物车当前为空
iRucaparib-AP6, a non-trapping PARP1 degrader, blocks both the catalytic activity and scaffolding effects of PARP1. iRucaparib-AP6 is a highly efficient and specific PARP1 degrader based on Rucaparib by using the PROTAC approach.
为众多的药物研发团队赋能,
让新药发现更简单!
iRucaparib-AP6, a non-trapping PARP1 degrader, blocks both the catalytic activity and scaffolding effects of PARP1. iRucaparib-AP6 is a highly efficient and specific PARP1 degrader based on Rucaparib by using the PROTAC approach.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 4,570 | 期货 | |
5 mg | ¥ 13,700 | 期货 | |
10 mg | ¥ 23,700 | 期货 | |
50 mg | 询价 | 期货 | |
100 mg | 询价 | 期货 |
产品描述 | iRucaparib-AP6, a non-trapping PARP1 degrader, blocks both the catalytic activity and scaffolding effects of PARP1. iRucaparib-AP6 is a highly efficient and specific PARP1 degrader based on Rucaparib by using the PROTAC approach. |
体外活性 | iRucaparib-AP6 (0-10 μM; 24 hours) decreases PARP-1 levels in a dose-dependent manner, with a half-maximal degrading concentration (DC50) of 82 nM (Dmax = 92%). |
分子量 | 886.96 |
分子式 | C46H55FN6O11 |
CAS No. | 2410557-00-3 |
密度 | 1.331 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 50 mg/mL (56.37 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容